These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9892485)

  • 1. Comparison of clinical outcome between histidine-triptophan-ketoglutalate solution and cold blood cardioplegic solution in mitral valve replacement.
    Sakata J; Morishita K; Ito T; Koshino T; Kazui T; Abe T
    J Card Surg; 1998 Jan; 13(1):43-7. PubMed ID: 9892485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial protection in donor heart preservation: a comparison between Bretschneider's histidine-tryptophan-ketoglutarate solution and cold blood cardioplegia.
    Sung SY; Lin CY; Song JY; Tsai YT; Kao CH; Lee CY; Lin YC; Hsu PS; Tsai CS
    Transplant Proc; 2014 May; 46(4):1077-81. PubMed ID: 24815133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial protection using HTK solution in minimally invasive mitral valve surgery.
    Savini C; Camurri N; Castelli A; Dell'Amore A; Pacini D; Suarez SM; Grillone G; Di Bartolomeo R
    Heart Surg Forum; 2005; 8(1):E25-7. PubMed ID: 15769709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioprotection by sevoflurane against reperfusion injury after cardioplegic arrest in the rat is independent of three types of cardioplegia.
    Ebel D; Preckel B; You A; Müllenheim J; Schlack W; Thämer V
    Br J Anaesth; 2002 Jun; 88(6):828-35. PubMed ID: 12173202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical impact of histidine-ketoglutarate-tryptophan (HTK) cardioplegic solution on the perioperative period in open heart surgery patients.
    Careaga G; Salazar D; Téllez S; Sánchez O; Borrayo G; Argüero R
    Arch Med Res; 2001; 32(4):296-9. PubMed ID: 11440787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enflurane and isoflurane, but not halothane, protect against myocardial reperfusion injury after cardioplegic arrest with HTK solution in the isolated rat heart.
    Preckel B; Schlack W; Thämer V
    Anesth Analg; 1998 Dec; 87(6):1221-7. PubMed ID: 9842801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of single-dose histidine-tryptophan-ketoglutarate cardioplegia during minimally invasive mitral valve surgery.
    Savini C; Murana G; Di Eusanio M; Suarez SM; Jafrancesco G; Castrovinci S; Castelli A; Di Bartolomeo R
    Innovations (Phila); 2014; 9(6):416-20. PubMed ID: 25251549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The myocardial protection of HTK cardioplegic solution on the long-term ischemic period in pediatric heart surgery.
    Liu J; Feng Z; Zhao J; Li B; Long C
    ASAIO J; 2008; 54(5):470-3. PubMed ID: 18812735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial of HTK versus warm blood cardioplegia for right ventricular protection in mitral surgery.
    Gaudino M; Pragliola C; Anselmi A; Pieroni M; De Paulis S; Leone A; De Caterina AR; Massetti M
    Scand Cardiovasc J; 2013 Dec; 47(6):359-67. PubMed ID: 24053647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One single dose of histidine-tryptophan-ketoglutarate solution gives equally good myocardial protection in elective mitral valve surgery as repetitive cold blood cardioplegia: a prospective randomized study.
    Braathen B; Jeppsson A; Scherstén H; Hagen OM; Vengen Ø; Rexius H; Lepore V; Tønnessen T
    J Thorac Cardiovasc Surg; 2011 Apr; 141(4):995-1001. PubMed ID: 20800244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of myocardial preservation using HTK solution in continuous 120 min cross-clamping method--a comparative study with GIK method].
    Hachida M; Bonkohara Y; Nonoyama M; Toyama A; Saitou S; Nemoto S; Satou M; Katsumata T; Imamaki M; Koyanagi H
    Nihon Kyobu Geka Gakkai Zasshi; 1993 Sep; 41(9):1495-501. PubMed ID: 8409603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial Protection and Financial Considerations of Custodiol Cardioplegia in Minimally Invasive and Open Valve Surgery.
    Hummel BW; Buss RW; DiGiorgi PL; Laviano BN; Yaeger NA; Lucas ML; Comas GM
    Innovations (Phila); 2016; 11(6):420-424. PubMed ID: 27879532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of HTK solution for myocardial preservation.
    Hachida M; Ookado A; Nonoyama M; Koyanagi H
    J Cardiovasc Surg (Torino); 1996 Jun; 37(3):269-74. PubMed ID: 8698763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New HTK-N46B cardioplegia provides superior protection during ischemia/reperfusion in failing hearts.
    Trescher K; Hasun M; Baumgartner A; Dietl W; Wolfsberger M; Hallström S; Podesser BK
    J Cardiovasc Surg (Torino); 2013 Jun; 54(3):413-21. PubMed ID: 23389583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidose cold oxygenated blood is superior to a single dose of Bretschneider HTK-cardioplegia in the pig.
    Fannelop T; Dahle GO; Salminen PR; Moen CA; Matre K; Mongstad A; Eliassen F; Segadal L; Grong K
    Ann Thorac Surg; 2009 Apr; 87(4):1205-13. PubMed ID: 19324152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of terminal warm blood cardioplegia in combination with Bretschneider-HTK solution for myocardial protection].
    Morishita A; Kitamura M; Ishitoya H; Hachida M; Endoh M; Koyanagi H
    Kyobu Geka; 1999 Sep; 52(10):831-5. PubMed ID: 10478544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histidine-tryptophan-ketoglutarate solution versus multidose cardioplegia for myocardial protection in cardiac surgeries: a systematic review and meta-analysis.
    Albadrani M
    J Cardiothorac Surg; 2022 May; 17(1):133. PubMed ID: 35642063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial reperfusion with magnesium after cardioplegic arrest attenuates myocardial reperfusion injury.
    Fuchs F; Messmer K; Kuppe H; Habazettl H
    Thorac Cardiovasc Surg; 2002 Aug; 50(4):208-15. PubMed ID: 12165870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which is the better option during neonatal cardiopulmonary bypass: HTK solution or cold blood cardioplegia?
    Chen Y; Liu J; Li S; Li W; Yan F; Sun P; Wang H; Long C
    ASAIO J; 2013; 59(1):69-74. PubMed ID: 23263337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose histidine-tryptophan-ketoglutarate solution for myocardial protection.
    Arslan A; Sezgin A; Gultekin B; Ozkan S; Akay T; Uguz E; Tasdelen A; Aslamaci S
    Transplant Proc; 2005 Sep; 37(7):3219-22. PubMed ID: 16213352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.